Clinical Trial Update: Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjunctive Vivomixx in patients with cirrhosis and spontaneous bacterial peritonitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Vivomixx (Probiotic formulation)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: WITHDRAWN